{"pr_nif_0000_21981_1": {
  "e_uid": "NIDA-CPU-0016",
  "studynum": "NIDA-CPU-0016",
  "investigator": "Eugene Somoza, M.D.",
  "study_title": "Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Methamphetamine And Osmotic-Release Methylphenidate (Oros-Mph)",
  "release_date": "2014-12-04",
  "study_description": "The primary objective of this study is to determine the safety of the OROS-MPH concurrent with i.v. d-methamphetamine infusions of 15 mg and 30 mg. Safety outcome measures include cardiovascular responses [heart rate (HR), blood pressure (BP), and electrocardiograph (ECG) measurements], oral temperature, adverse events (AEs), and clinical laboratory analyses.",
  "keywords": "Phase 1B, Oral Osmotic-release, Methylphenidate, Methamphetamine, Intravenous, Stimulant",
  "url": "https://datashare.nida.nih.gov/protocol/nida-cpu-0016",
  "v_uid": "NIDA-CPU-0016",
  "v_uuid": "98af5329-6e98-5472-bcf0-3c7c69685d3a",
  "v_lastmodified": "2016-04-07 12:43:22.048079",
  "v_status": "E",
  "v_lastmodified_epoch": 1.460033002048079E9
}}
